Day One Biopharmaceuticals Inc — Balance Sheet (NASDAQ:DAWN) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 289.82 M349.06 M376.05 M582.79 M507.83 M Total liabilities 8.67 M17.02 M29.51 M80.04 M66.67 M Total equity 281.15 M332.04 M346.54 M502.75 M441.16 M Total liabilities & shareholders' equities 289.82 M349.06 M376.05 M582.79 M507.83 M Total debt ————— Net debt —————

Notizie

Needham riduce il target di prezzo di Day One Biopharmaceuticals per i costi

Needham lowers Day One Biopharmaceuticals price target on costs

H.C. Wainwright riduce il target di Day One Biopharmaceuticals a $22

H.C. Wainwright lowers Day One Biopharmaceuticals price target to $22

Day One Biopharmaceuticals, Inc. (DAWN) Q4 2025 Earnings Call Transcript

Day One Biopharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:DAWN) 2026-02-25

Gli EPS di Day One Biopharmaceuticals hanno mancato le aspettative per 0,02$, il fatturato supera le previsioni

Day One Biopharmaceuticals earnings missed by $0.02, revenue topped estimates

Day One Biopharmaceuticals supera le stime sui ricavi

Day One Biopharmaceuticals beats revenue estimates

Day One Biopharmaceuticals: risultati in arrivo dopo l’accordo Mersana

Day one Biopharma CCO sold $67k in DAWN stock